Table 2.
Individual race | Breast | Colorectal | Prostate | Lung | ||||
---|---|---|---|---|---|---|---|---|
Black | Hispanic | Black | Hispanic | Black | Hispanic | Black | Hispanic | |
Odds ratio (relative to whites) | ||||||||
Age (ref: 65–74 years) | ||||||||
75–84 | 0.92* | 0.92* | 1.05* | 1.03 | 0.48* | 0.47* | 1.06 * | 1.07* |
≥85 | 0.81* | 0.80* | 1.10* | 1.09* | 0.21* | 0.21* | 0.92* | 0.92* |
Sex (ref: female) | ||||||||
Male | 0.90* | 0.90* | 0.83* | 0.82* | ||||
Ever eligible state buy-in coverage (ref: no) | ||||||||
Yes | 0.93 | 0.99 | 1.19* | 1.22* | 0.72* | 0.75* | 1.26* | 1.24* |
Charlson comorbidity score:(ref: none) | ||||||||
1 | 1.30* | 1.31* | 1.13* | 1.11* | 1.25* | 1.20* | 1.42* | 1.43* |
2 | 1.27* | 1.27* | 1.23* | 1.20* | 0.95 | 0.94 | 1.47* | 1.48* |
>3 | 1.15 | 1.11 | 1.25* | 1.23* | 0.90 | 0.84* | 1.37* | 1.35* |
Models adjusted for age, race/ethnicity, sex (for individuals with colorectal and lung cancer), marital status, comorbidity, eligibility for state buy-in coverage, cancer type, year of diagnosis, Medicare coverage in the 13 months before diagnosis, HMO coverage after diagnosis, urban/rural indicator, area category (segregation/income), and interaction terms between race and area categories.
*Comparison of blacks or Hispanics to whites significant at P < .05